At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SI Shoulder Innovations, Inc.
Closed 07-17 16:00:00 EDT
21.59
-0.94
-4.17%
盘后21.59
+0.000.00%
16:10 EDT
High22.92Low21.48Vol80.54K
Open22.31D1 Closing22.53Amplitude6.39%
Mkt Cap447.52MTradable Cap107.95MTotal Shares20.73M
T/O1.77MT/O Rate1.61%Tradable Shares5.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Truist Securities Adjusts Price Target on SI-BONE to $21 From $18, Maintains Buy Rating
MT Newswires Live  ·  07-16 20:57
Truist Securities Adjusts Price Target on SI-BONE to $21 From $18, Maintains Buy Rating
Shoulder Innovations to Report Q2 Financial Results After Market Close, Host Conference Call
Reuters  ·  07-15
Shoulder Innovations to Report Q2 Financial Results After Market Close, Host Conference Call
Two SI-Bone Insiders Quietly Cash In With Fresh Stock Sales
TIPRANKS  ·  07-07
Two SI-Bone Insiders Quietly Cash In With Fresh Stock Sales
Tenon Medical's Catamaran SI Joint Fusion System Gets FDA 510(k) Clearance; Shares Rise Pre-Bell
MT Newswires Live  ·  07-02
Tenon Medical's Catamaran SI Joint Fusion System Gets FDA 510(k) Clearance; Shares Rise Pre-Bell
Press Release: Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
Dow Jones  ·  06-29
Press Release: Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
Shoulder Innovations Shareholders Ratify Deloitte as Auditor for 2026
Reuters  ·  06-27
Shoulder Innovations Shareholders Ratify Deloitte as Auditor for 2026
Shoulder Innovations COO Matthew Fraser Ahearn sells USD 373,787 of common shares
Reuters  ·  06-17
Shoulder Innovations COO Matthew Fraser Ahearn sells USD 373,787 of common shares
BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
Reuters  ·  06-11
BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
Gold, silver slide as rate risk overwhelms haven demand - Kitco PM Report
Kitco  ·  06-09
Gold, silver slide as rate risk overwhelms haven demand - Kitco PM Report
Insider Move: SI-Bone Director’s Latest Stock Sale Raises Eyebrows
TIPRANKS  ·  06-09
Insider Move: SI-Bone Director’s Latest Stock Sale Raises Eyebrows
SI-BONE Shareholders Endorse Governance and Lease Amendment
TIPRANKS  ·  06-09
SI-BONE Shareholders Endorse Governance and Lease Amendment
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
GlobeNewswire  ·  06-05
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
Analyst Reaffirms Buy on SI-Bone, Keeps $27 Price Target Amid Confidence in Growth and Profitability Outlook
TIPRANKS  ·  06-03
Analyst Reaffirms Buy on SI-Bone, Keeps $27 Price Target Amid Confidence in Growth and Profitability Outlook
Insider Move at SI-Bone: Director’s Stock Sale Turns Heads on Wall Street
TIPRANKS  ·  06-02
Insider Move at SI-Bone: Director’s Stock Sale Turns Heads on Wall Street
Shoulder Innovations management to attend Goldman Sachs Global Healthcare Conference
Reuters  ·  05-27
Shoulder Innovations management to attend Goldman Sachs Global Healthcare Conference
SI-Bone management to meet with Needham
TIPRANKS  ·  05-27
SI-Bone management to meet with Needham
Top SI-Bone Executives Quietly Unload Shares in Coordinated Insider Move
TIPRANKS  ·  05-21
Top SI-Bone Executives Quietly Unload Shares in Coordinated Insider Move
Shoulder Innovations (SI) Q1 Losses Deepen And Test Premium Growth Narrative
Simply Wall St.  ·  05-15
Shoulder Innovations (SI) Q1 Losses Deepen And Test Premium Growth Narrative
Analysts Offer Insights on Healthcare Companies: Shoulder Innovations, Inc. (SI), Maze Therapeutics, Inc. (MAZE) and PACS Group Inc (PACS)
TIPRANKS  ·  05-14
Analysts Offer Insights on Healthcare Companies: Shoulder Innovations, Inc. (SI), Maze Therapeutics, Inc. (MAZE) and PACS Group Inc (PACS)
BIOKIN's SI-B036 Bispecific Antibody Injection Receives Clinical Trial Approval for Advanced Solid Tumors
Stock News  ·  05-14
BIOKIN's SI-B036 Bispecific Antibody Injection Receives Clinical Trial Approval for Advanced Solid Tumors

Introduction

Company Name.
Shoulder Innovations, Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Issue price:
--